Security Snapshot

PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) Institutional Ownership

CUSIP: 70387R502

13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

18

Shares (Excl. Options)

935,854

Price

$5.94

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+423,920
Value change
+$2,515,199
Number of holders
18
Issuer context Names, identifiers, and filing context for this profile. 2 identity fields
Shares outstanding
7,952,023
SEC-reported price per share
$5.07
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 70387R502.
  • 18 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 20 to 18 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $5,197,728 to $5,558,973.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 18 institutions filings for Q2 2026.

Open SEC evidence

Security key

70387R502

Latest holder period

Q2 2026

13F holders

18

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
PAVM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NAGELBERG DAVID S 8.8% $4,156,681 699,778 NAGELBERG DAVID S 30 Jun 2026

As of 30 Jun 2026, 18 institutional investors reported holding 935,854 shares of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM). This represents 12% of the company’s total 7,952,023 outstanding shares.

13F concentration

Top 22 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
12%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Two Seas Capital LP 5.8% 461,539 0% 0.1% $2,741,542
FIRST MANHATTAN CO. LLC. 4.2% 332,911 +1298% 0.01% $1,977,491
VANGUARD CAPITAL MANAGEMENT LLC 0.77% 61,604 +941% 0% $365,928
GEODE CAPITAL MANAGEMENT, LLC 0.46% 36,678 +211% 0% $217,871
VANGUARD FIDUCIARY TRUST CO 0.32% 25,605 +372% 0% $152,094
BlackRock, Inc. 0.21% 17,092 +607% 0% $101,526
MORGAN STANLEY 0% 163 -1.2% 0% $968
BARCLAYS PLC 0% 75 0% $446
SBI Securities Co., Ltd. 0% 67 0% 0% $398
UBS Group AG 0% 57 -24% 0% $339
WELLS FARGO & COMPANY/MN 0% 45 0% 0% $267
Allworth Financial LP 0% 5 -17% 0% $30
OSAIC HOLDINGS, INC. 0% 4 0% 0% $21
Federation des caisses Desjardins du Quebec 0% 4 0% $23
Steward Partners Investment Advisory, LLC 0% 2 +100% 0% $12
Caitong International Asset Management Co., Ltd 0% 1 0% $6
JONES FINANCIAL COMPANIES LLLP 0% 1 0% 0% $5
BNP PARIBAS FINANCIAL MARKETS 0% 1 0% 0% $6
AdvisorNet Financial, Inc 0% 0 -100% $0
Tower Research Capital LLC (TRC) 0% 0 -100% $0
GROUP ONE TRADING LLC 0% 0 -100% $0
Vanguard Global Advisers, LLC 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
3
Latest
Q2 2026
Rows shown
1-3 of 3
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 935,854 $5,558,973 +$2,515,199 $5.94 18
2026 Q1 512,091 $5,197,728 +$5,066,429 $10.15 20
2025 Q4 65,160 $14,387 +$14,387 $0.22 3
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .